TIPARP and neoplasm: As shown in Fig 6I, administration of thioparib (10 mg/kg, qd) for 3 weeks significantly suppressed tumor growth compared with vehicle (P < 0.001) in the PARP1 KO MC38 model; however, no antitumor activity was observed in PARP7 KO tumor‐bearing mice.